NCT06493032

Brief Summary

The purpose of this study is to investigate whether or not the investigators can utilize Body Surface Gastric Mapping to determine who would best benefit to receive G-POEM procedure and how Body Surface Gastric Mapping can be utilized with patients who have gastroparesis symptoms. the investigators may also be able to find more ways how Body Surface Gastric Mapping testing can benefit patients with gastroparesis and/or G-POEM procedure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Nov 2024Jun 2026

First Submitted

Initial submission to the registry

May 24, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 9, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

November 7, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

1.6 years

First QC Date

May 24, 2024

Last Update Submit

February 16, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Body Surface Gastric Mapping Rhythm IndexTM (GA-RI)

    A measure of the concentration of amplitude in the gastric frequency band over time (between 0 and 1), which characterizes the rhythmic stability of the recorded gastric activity; also adjusted for BMI.

    Baseline, 3 months,6 months, up to 5 hours.

  • Principal Gastric Frequency

    Characterizes the frequency associated with stable, persistent gastric activity as defined by GA-R

    Baseline, 3 months,6 months, up to 5 hours.

  • BMI-Adjusted Amplitude (μV)

    characterizes the strength of the recorded gastric activity as an average of the whole-test amplitude, adjusted for BMI

    Baseline, 3 months,6 months, up to 5 hours.

  • Fed: Fasted Amplitude Ratio (ff-AR)

    characterizes the responsiveness to a meal stimulus, which is calculated as a ratio of the maximal 1-h average postprandial amplitude to the amplitude in the preprandial period.

    Baseline, 3 months,6 months, up to 5 hours.

  • SF-36

    a set of generic, coherent, and easily administered quality-of-life measures

    Baseline, 3 months,6 months, up to 5 hours.

Secondary Outcomes (1)

  • Body surface gastric mapping (BSMG)

    Baseline, 3 months,6 months, up to 5 hours.

Study Arms (1)

Body Surface Gastric Mapping

EXPERIMENTAL
Device: Gastric Alimetry System

Interventions

medical device that uses a large sheet of electrodes to assess gastric motility

Also known as: Body Surface Gastric Mapping, BSMG, Electrogastrography System
Body Surface Gastric Mapping

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients clinically eligible for G-Poem at our center.

You may not qualify if:

  • Pregnant or breast-feeding
  • Patients with gastroparesis due to spinal cord injuries due to difficulties in conducting the BSGM. Of note, we rarely see gastroparesis in this context.
  • Inability to perform BSGM: history of severe skin allergies or sensitivity to cosmetics or lotions; chronically damaged or vulnerable epigastric skin (fragile skin, wounds, inflammation); patients unable to remain in a relaxed reclined position for the test duration.
  • Patients with abdominal drains or tubes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University Health University Hospital

Indianapolis, Indiana, 46202, United States

RECRUITING

MeSH Terms

Conditions

Gastroparesis

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mohammad Al-Haddad, MD

    Indiana Unversity/Indiana University Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jacqueline Peterman

CONTACT

Marita Salame, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: enrolling 20 participants who are being referred for G-POEM procedure into this study for a baseline alimetry and then again at 3-6 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 24, 2024

First Posted

July 9, 2024

Study Start

November 7, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations